Repeat Dosing of AAV2.5T to Ferret Lungs Elicits an Antibody Response That Diminishes Transduction in an Age-Dependent Manner

Readministration of recombinant adeno-associated virus (rAAV) may be necessary to treat cystic fibrosis (CF) lung disease using gene therapy. However, little is known about rAAV-mediated immune responses in the lung. Here, we demonstrate the suitability of the ferret for testing AAV2.5T-mediated CFT...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Yinghua, Yan, Ziying, Lin, Shen, Huntemann, Eric D., Feng, Zehua, Park, Soo-Yeun, Sun, Xingshen, Yuen, Eric, Engelhardt, John F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648090/
https://www.ncbi.nlm.nih.gov/pubmed/33209961
http://dx.doi.org/10.1016/j.omtm.2020.09.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648090/
https://www.ncbi.nlm.nih.gov/pubmed/33209961
http://dx.doi.org/10.1016/j.omtm.2020.09.008

Ejemplares similares